From the biological aspect, none of the CD3, CD4, and other immunophenotypes can be considered as a surrogate of the extreme heterogeneity and functional diversity of these lymphocytic populations in the tumor microenvironment (44). The gene discussed is CD4; the disease is neoplasm.